Skip to main content
. 2020 Aug 7;57(4):967–979. doi: 10.3892/ijo.2020.5106

Figure 8.

Figure 8

LUCAT1 overexpression promotes tumor growth and cisplatin resistance in vivo. (A and B) Tumor volume was measured each week and tumor weight was measured after 6 weeks. (C and D) The expression levels of LUCAT1, miR-514a-3p and ULK1 mRNA in tumor samples were detected by RT-qPCR, and the protein level of ULK1 was determined by western blot analysis. *P<0.05 vs. the respective control. LUCAT1, lung cancer-associated transcript 1; ULK1, uncoordinated-51-like kinase 1; DDP, cisplatin.